The two journalistic wealth trackers agree the Trump meme coin hasn't added anything to the president's wealth - yet. Donald Trump launched a meme coin in the days before his return to the White House ...
With help from the precision scheduled railroading playbook, CSX's adjusted OR improved to 58.1% in 2022, from 66.5% in 2017. Despite setbacks over the past few years, we expect CSX to rekindle OR ...
The RSI can be a tricky indicator. When it's below 30, it suggests an "oversold" condition, which, over the short-term, might suggest a bounce is due. And when it's above the "overbought" threshold of ...
"At the World Economic Forum in Davos on Thursday, U.S. President Donald Trump reiterated his threat to use tariffs to bring manufacturing back to the U.S.," said Solita Marcelli, chief investment ...
Over the past year, companies like Walmart Inc. (WMT) - one of Target's main rivals - McDonald's Corp. (MCD) and others have also rolled back their diversity goals. Before Trump's election, some ...
Moody's Ratings upgraded Argentina's currency ratings as high inflation and government debt are beginning to ease. The ratings firm also changed its outlook to positive from stable.
The law was designed to shut down TikTok in the U.S. as of Sunday if the app continued to be controlled by ByteDance. Thanks to Trump's promise on Sunday that he would give TikTok more time once he ...
I have a pretty good amount in my IRA ($500,000) that I have contributed to for years. I also funded my husband's IRA spousal account ($70,000) as he seldom worked and made zero contributions himself.
Citigroup (C) and Evercore ISI are acting as book-running managers for the proposed IPO and as representatives of the underwriters. RBC Capital Markets and William Blair are acting as joint ...
U.S. existing-home sales fell in 2024 to the lowest level in 30 years, as high mortgage rates and low housing inventory weighed on home-buying activity.
To subscribe to Barron's, visit http://www.barrons.com/subscribe January 24, 2025 21:45 ET (02:45 GMT) ...
Pfizer will pay $60 million to settle allegations that one of its subsidiaries incentivized healthcare providers to prescribe one of its drugs, resulting in the submission of false claims to federal ...